Developer docs
API playgroundTry for free, no card

Search company profiles

CapVest

Full company profile

uuid00004ea

Namestring
CapVest
Legal namestring
CapVest Partners LLP
Websiteurl
capvest.co.uk
Company typeenum
Private
Founded yearint
1999
Descriptiontext

CapVest is a London-headquartered private equity firm founded in 1999 that invests as a principal in controlling stakes of mid-to-large-sized companies operating in non-discretionary end markets — primarily consumer staples, healthcare, and essential services. The firm maintains a deliberately concentrated portfolio (sources list roughly a dozen active platforms) and supports portfolio company management with patient capital for both organic growth and acquisition-led consolidation, positioning itself as a sector consolidator rather than a financial-engineering buyer.

CapVest's revenue model is standard for a mid-to-large-cap buyout firm: it raises capital from institutional Limited Partners into closed-end funds (referenced as "Fund III" in firmographic data) and earns a combination of management fees on committed/invested capital and carried interest on realizations. The firm does not sell products or services to end customers; instead, its customers are institutional LPs (pension funds, endowments, family offices) who commit capital to successive vehicles. CapVest's operating footprint spans London (headquarters), New York, and Dublin, with portfolio company operations covering Europe (UK, Germany, France, Nordics, Benelux, Central Europe) and North America.

The platform has executed multiple large transactions over 2025–2026, including the €10 billion STADA Arzneimittel AG buyout in March 2026, a $7 billion continuation-vehicle recapitalization of Curium in November 2025, the announced €1.8 billion acquisition of TSG in February 2026, and the $500 million commitment to expand Datasite including its acquisition of Blueflame AI. Other notable holdings include Natra (chocolate, acquired from Investindustrial at ~€500 million), Inspired Pet Nutrition, Performance Fluids Experts Group/Recochem, NextPharma, Klipboard/Kerridge Commercial Systems, Rodericks Dental Partners, and Second Nature Brands. The portfolio strategy emphasizes resilient, non-cyclical demand drivers, with bolt-on activity within platforms (e.g., Natra's acquisition of Gudrun, Inspired Pet Nutrition's pursuit of Ultra Premium Direct and Sopral) supporting a build-and-consolidate thesis.

Short descriptiontext

CapVest is a London-based private equity firm founded in 1999 that acquires controlling stakes in mid-to-large companies across consumer staples, healthcare, and essential services, supporting management teams with patient capital for organic and acquisition-led growth.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
private equity investment, portfolio management services, buyout fund management, control stake acquisitions, institutional fund investing
NAICS code2 codes
  • Portfolio Management and Investment Advice523940
  • Other Financial Vehicles52599
Product category
Private Equity Investment Management
Social media profiles1 record
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

CapVest is a private equity investment firm that acquires controlling stakes in companies operating in highly resilient industries with non-discretionary demand, including consumer staples, healthcare, and essential services. The firm partners with management teams to transform portfolio company size and scale through both organic growth initiatives and acquisition-led strategies, deploying patient capital with a long-term horizon.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • STADA achieved record revenues of €4.3 billion and adjusted EBITDA of €961 million in 2025 under CapVest's ownership
+2 more records
Product overview1 text field

CapVest is a private equity investment firm that does not offer a unified product or platform in the traditional SaaS sense. Rather than operating a product business, CapVest acquires and manages controlling stakes in portfolio companies across healthcare, consumer staples, and essential services sectors. The firm focuses on transforming the size and scale of portfolio companies through both organic growth and acquisition-led strategies. CapVest is not a product company and therefore has no products or services in its own portfolio to describe.

Product and service2 records
1Private Equity Fund Management
CategoryPrivate Equity Fund Management
Description

CapVest raises capital from institutional investors including pension funds, endowments, and family offices through private equity fund vehicles, and deploys that capital to acquire controlling stakes in companies in resilient industries.

2Portfolio Company Transformation Services
CategoryInvestment Management Services
Description

CapVest partners with management teams of portfolio companies to transform their size and scale through organic growth initiatives and acquisition-led strategies, providing active and engaged dialogue, fast decision-making, and additional capital deployment.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-31
Description

CapVest completed acquisition of a majority stake in STADA, a global healthcare and pharmaceuticals company. STADA reported record revenues of €4.3 billion and adjusted EBITDA of €961 million in 2025, with nearly 12,000 employees worldwide.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-08-11
Description

CapVest Partners committed $500 million toward expanding Datasite's intelligence solutions organically and inorganively. This investment enabled Datasite to acquire Blueflame AI, a leading provider of agentic AI solutions for investment and financial services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

BC Partners is a London-based mid-to-large-cap private equity firm with a similar sector focus on consumer, healthcare, and industrials/services in Europe. Comparable in size, deal cadence, and cross-border European buyout activity to CapVest.

TypeDirect peer
Description

UK-headquartered mid-market private equity firm investing in consumer, healthcare, and business services across Europe. Similar in scale, sector tilt, and patient-capital approach to CapVest.

TypeDirect peer
Description

Large European-headquartered private equity firm with deep exposure to healthcare (Galderma, Karo Healthcare) and consumer/essential services. Closely comparable business model to CapVest including healthcare platform building.

TypeDirect peer
Description

Pan-European private equity firm focused on healthcare, consumer, and services. Just sold STADA majority to CapVest consortium, evidencing direct peer overlap in mega-cap European healthcare buyouts.

TypeDirect peer
Description

European private equity firm investing in mid-to-large-cap consumer, healthcare, and business services. Similar fund size, sector coverage, and patient capital approach as CapVest.

TypeDirect peer
Description

European mid-market private equity firm with a comparable sector focus on consumer and healthcare. Previously sold NextPharma to CapVest, evidencing overlapping deal universe in European pharma services and consumer.

TypeBroad incumbent
Description

Global mega-fund private equity platform with broad sector exposure including consumer, healthcare, and services. Co-sold STADA to CapVest, evidencing direct deal-overlap at the large-cap end of CapVest's strategy.

TypeBroad incumbent
Description

Global mega-fund private equity firm with broad healthcare, consumer, and infrastructure exposure. Competes with CapVest for large-cap European deals and is referenced in the same market context.

TypeBroad incumbent
Description

Global alternative asset manager raising record sums for energy transition and credit strategies. Cited in the same market context as CapVest and a competitor for large European essential-services and infrastructure deals (e.g., TSG).

10Ardian
TypeDirect peer
Description

Paris-based private investment house with European mid-to-large-cap buyout activity across consumer, healthcare, and services. Similar fund size, deal cadence, and patient-capital European mid-market positioning as CapVest.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries11 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A22 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CapVest

Private Equity Investment Managementcapvest.co.uk

CapVest is a London-based private equity firm founded in 1999 that acquires controlling stakes in mid-to-large companies across consumer staples, healthcare, and essential services, supporting management teams with patient capital for organic and acquisition-led growth.

What CapVest does

CapVest is a London-headquartered private equity firm founded in 1999 that invests as a principal in controlling stakes of mid-to-large-sized companies operating in non-discretionary end markets — primarily consumer staples, healthcare, and essential services. The firm maintains a deliberately concentrated portfolio (sources list roughly a dozen active platforms) and supports portfolio company management with patient capital for both organic growth and acquisition-led consolidation, positioning itself as a sector consolidator rather than a financial-engineering buyer.

CapVest's revenue model is standard for a mid-to-large-cap buyout firm: it raises capital from institutional Limited Partners into closed-end funds (referenced as "Fund III" in firmographic data) and earns a combination of management fees on committed/invested capital and carried interest on realizations. The firm does not sell products or services to end customers; instead, its customers are institutional LPs (pension funds, endowments, family offices) who commit capital to successive vehicles. CapVest's operating footprint spans London (headquarters), New York, and Dublin, with portfolio company operations covering Europe (UK, Germany, France, Nordics, Benelux, Central Europe) and North America.

The platform has executed multiple large transactions over 2025–2026, including the €10 billion STADA Arzneimittel AG buyout in March 2026, a $7 billion continuation-vehicle recapitalization of Curium in November 2025, the announced €1.8 billion acquisition of TSG in February 2026, and the $500 million commitment to expand Datasite including its acquisition of Blueflame AI. Other notable holdings include Natra (chocolate, acquired from Investindustrial at ~€500 million), Inspired Pet Nutrition, Performance Fluids Experts Group/Recochem, NextPharma, Klipboard/Kerridge Commercial Systems, Rodericks Dental Partners, and Second Nature Brands. The portfolio strategy emphasizes resilient, non-cyclical demand drivers, with bolt-on activity within platforms (e.g., Natra's acquisition of Gudrun, Inspired Pet Nutrition's pursuit of Ultra Premium Direct and Sopral) supporting a build-and-consolidate thesis.

CapVest firmographics

Firmographics
Name
CapVest
Legal name
CapVest Partners LLP
Website
https://capvest.co.uk
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
51–100 employees
Short description
CapVest is a London-based private equity firm founded in 1999 that acquires controlling stakes in mid-to-large companies across consumer staples, healthcare, and essential services, supporting management teams with patient capital for organic and acquisition-led growth.
Ownership category
akta.pro rank

Where CapVest is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

CapVest business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Distribution channels1 record

Marketing channels2 records

CapVest product offering

Product offering

Core offering

CapVest is a private equity investment firm that acquires controlling stakes in companies operating in highly resilient industries with non-discretionary demand, including consumer staples, healthcare, and essential services. The firm partners with management teams to transform portfolio company size and scale through both organic growth initiatives and acquisition-led strategies, deploying patient capital with a long-term horizon.

Product overview

CapVest is a private equity investment firm that does not offer a unified product or platform in the traditional SaaS sense. Rather than operating a product business, CapVest acquires and manages controlling stakes in portfolio companies across healthcare, consumer staples, and essential services sectors. The firm focuses on transforming the size and scale of portfolio companies through both organic growth and acquisition-led strategies. CapVest is not a product company and therefore has no products or services in its own portfolio to describe.

Differentiator

Problem solved

Functional benefit

Products and services

  • Private Equity Fund Management CapVest raises capital from institutional investors including pension funds, endowments, and family offices through private equity fund vehicles, and deploys that capital to acquire controlling stakes in companies in resilient industries.
  • Portfolio Company Transformation Services CapVest partners with management teams of portfolio companies to transform their size and scale through organic growth initiatives and acquisition-led strategies, providing active and engaged dialogue, fast decision-making, and additional capital deployment.

Quantifiable outcome

  • STADA achieved record revenues of €4.3 billion and adjusted EBITDA of €961 million in 2025 under CapVest's ownership
  • +2 more outcomes

Companies that use CapVest

Customer profile

Segments3 records

Ideal customer profiles2 records

CapVest technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CapVest partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • STADA Arzneimittel AGcoreStrategic or Co-development Partner · 31 March 2026CapVest completed acquisition of a majority stake in STADA, a global healthcare and pharmaceuticals company. STADA reported record revenues of €4.3 billion and adjusted EBITDA of €961 million in 2025, with nearly 12,000 employees worldwide.
  • DatasitecoreStrategic or Co-development Partner · 11 August 2025CapVest Partners committed $500 million toward expanding Datasite's intelligence solutions organically and inorganively. This investment enabled Datasite to acquire Blueflame AI, a leading provider of agentic AI solutions for investment and financial services.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

CapVest competitors and assessment

Company assessment

Direct peers

  • BC Partners: BC Partners is a London-based mid-to-large-cap private equity firm with a similar sector focus on consumer, healthcare, and industrials/services in Europe. Comparable in size, deal cadence, and cross-border European buyout activity to CapVest.
  • Charterhouse Capital Partners: UK-headquartered mid-market private equity firm investing in consumer, healthcare, and business services across Europe. Similar in scale, sector tilt, and patient-capital approach to CapVest.
  • EQT Partners: Large European-headquartered private equity firm with deep exposure to healthcare (Galderma, Karo Healthcare) and consumer/essential services. Closely comparable business model to CapVest including healthcare platform building.
  • Cinven: Pan-European private equity firm focused on healthcare, consumer, and services. Just sold STADA majority to CapVest consortium, evidencing direct peer overlap in mega-cap European healthcare buyouts.
  • PAI Partners: European private equity firm investing in mid-to-large-cap consumer, healthcare, and business services. Similar fund size, sector coverage, and patient capital approach as CapVest.
  • Sun European Partners: European mid-market private equity firm with a comparable sector focus on consumer and healthcare. Previously sold NextPharma to CapVest, evidencing overlapping deal universe in European pharma services and consumer.
  • Ardian: Paris-based private investment house with European mid-to-large-cap buyout activity across consumer, healthcare, and services. Similar fund size, deal cadence, and patient-capital European mid-market positioning as CapVest.

Broad incumbents

  • Bain Capital: Global mega-fund private equity platform with broad sector exposure including consumer, healthcare, and services. Co-sold STADA to CapVest, evidencing direct deal-overlap at the large-cap end of CapVest's strategy.
  • KKR: Global mega-fund private equity firm with broad healthcare, consumer, and infrastructure exposure. Competes with CapVest for large-cap European deals and is referenced in the same market context.
  • Apollo Global Management: Global alternative asset manager raising record sums for energy transition and credit strategies. Cited in the same market context as CapVest and a competitor for large European essential-services and infrastructure deals (e.g., TSG).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights6 records

Customer concentration

CapVest social profiles

Digital presence

CapVest financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CapVest leadership team

Management profile

Number of profiles

CapVest subsidiaries and ownership

Company hierarchy

Subsidiaries11 records

CapVest funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CapVest M&A and investment

M&A and investment

M&A22 records

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CapVest

What does CapVest do?

CapVest is a private equity investment firm that acquires controlling stakes in companies operating in highly resilient industries with non-discretionary demand, including consumer staples, healthcare, and essential services. The firm partners with management teams to transform portfolio company size and scale through both organic growth initiatives and acquisition-led strategies, deploying patient capital with a long-term horizon.

Is CapVest a public or private company?

CapVest is a private company. It is classified as private equity controlled and is currently operating.

When was CapVest founded?

CapVest was founded in 1999. It employs 51 to 100 people.

Where is CapVest based?

CapVest is headquartered in London, United Kingdom, in the Europe region.

Who are CapVest's main competitors?

Direct peers on record are BC Partners, Charterhouse Capital Partners, EQT Partners, Cinven, PAI Partners, Sun European Partners and Ardian. Broad incumbents are Bain Capital, KKR and Apollo Global Management.

Does CapVest have an API?

No public API is recorded for CapVest.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireApollo among suitors for €7bn spreads giant FloraApollo Global Management and Capvest are among private equity firms submitting initial offers for Flora Food Group, a spreads giant. KKR, the current majority shareholder, is seeking at least €7bn, while the company carries billions in debt and has reported weak growth.EIN PresswireApollo among suitors for €7bn spreads giant FloraApollo Global Management and Capvest are among private equity firms submitting initial offers for Flora Food Group, a spreads giant. KKR, the current majority shareholder, is seeking at least €7bn, while the company carries billions in debt and has reported weak growth.FAZ.NETAuslandsinvestitionen in Deutschland steigen um 50 ProzentForeign investment in Germany rose significantly last year, with UK investment increasing while US investment fell. The UK investor Capvest acquired a majority stake in German pharmaceutical company Stada, illustrating the trend.FinancialContent Business PageYukon Supports CapVest Partners and Second Nature Brands with the Acquisition of Tillamook Country SmokerYukon Partners announced mezzanine financing to Second Nature Brands (SNB) to support SNB's acquisition of Tillamook Country Smoker, a leader in protein-rich clean label meat snacks. The transaction marks SNB's first entry into the fast-growing protein snacks category, valued at over $5 billion, combining Tillamook with SNB's existing portfolio of seven premium snack brands including Kar's Nuts, Voortman, and Brownie Brittle. SNB is a portfolio company of CapVest Partners, and the combined entity is positioned as an asset of scale with strong brands across attractive categories.The CurrencyCurium, backed by Irish-led private equity firm CapVest, seeks to buy peer for $8bn - The CurrencyCurium, a radiopharmaceutical company backed by Irish-led private equity firm CapVest, has agreed to acquire peer Lantheus Holdings in a deal worth up to $8 billion, representing a per-share consideration of up to $114.50. The transaction, unanimously approved by Lantheus's board of directors, would create a combined entity spanning diagnostics and therapeutics with the capability to serve patients in more than 70 countries. CapVest, which established Curium in 2017 by merging IBA Molecular and Mallinckrodt, currently manages $20 billion in assets under management.Business Wire BlogYukon Supports CapVest Partners and Second Nature Brands with the Acquisition of Tillamook Country SmokerSecond Nature Brands, a portfolio company of CapVest Partners, has acquired Tillamook Country Smoker with mezzanine financing provided by Yukon Partners. This transaction marks Second Nature Brands' entry into the protein snacks category, combining its existing snack portfolio with Tillamook's clean-label meat snacks. The deal aims to leverage joint expertise to expand distribution and growth within the fast-growing $5 billion protein snacks market.BenzingaLantheus Stock Is Gaining Monday: What's Going On? - Lantheus Holdings (NASDAQ:LNTH)CapVest Partners LLP's portfolio company Curium agreed to acquire Lantheus Holdings Inc. in a deal valued at up to $8 billion, combining diagnostic and therapeutic radiopharmaceutical capabilities.BitlyCapvest Partners-backed Curium to acquire radiopharma biotech Lantheus for up to $8BCapVest Partners-backed Curium has agreed to acquire radiopharma company Lantheus for up to $8 billion in a deal that would take Lantheus private. The transaction represents a significant bet on the blockbuster potential of radiopharmaceuticals, a sector attracting larger investments from private equity firms. The acquisition highlights growing consolidation in the radiopharma space as companies position for anticipated market growth.Pulse 2.0CapVest Completes Acquisition Of Majority Stake In TSG SolutionsCapVest Partners has completed its acquisition of a majority stake in TSG Solutions, a European energy infrastructure services provider, following receipt of all required approvals. TSG is headquartered in Paris with operations across 30 countries, over 7,000 employees and annual revenue exceeding €1.4 billion; the company's management team and existing investor HLD reinvested alongside CapVest, with both retaining significant minority stakes. CapVest plans to support TSG's organic growth while accelerating its acquisition strategy, driven by increased investment in electrification and critical energy infrastructure across Europe.citybizCapVest Completes Majority Acquisition of Energy Infrastructure Services Firm TSGCapVest has completed its acquisition of a majority stake in TSG Solutions, a Paris-based European energy infrastructure services provider, after receiving all required regulatory approvals, giving the New York- and London-based private equity firm a controlling interest. TSG operates in 30 countries across Europe and Africa, employs more than 7,000 people and generates annual revenue exceeding €1.4 billion, providing engineering, installation and maintenance services for critical energy infrastructure including electrical systems, EV charging networks, solar installations and battery storage. Under CapVest's ownership, TSG plans to accelerate its acquisition strategy and consolidate Europe's fragmented technical services market, with existing management and former majority investor HLD retaining significant minority stakes following the transaction.